Immunogen's $6,220 ovarian cancer drug to be shipped within days
(Reuters) - Drugmaker Immunogen said on Tuesday it will sell its newly approved ovarian cancer drug at a list price of $6,220 per vial and start shipp...
Source: whbl.com
Page 7 - Mark Enyedy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Enyedy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Enyedy Today - Breaking & Trending Today
ImmunoGen commercial chief to withdraw before drug launch
The executive is leaving just prior to a scheduled regulatory decision on the biotech’s lead asset.
Source: mmm-online.com
ImmunoGen (IMGN) Q2 2022 Earnings Call Transcript
IMGN earnings call for the period ending June 30, 2022.
Source: fool.com
Investegate |Ergomed plc Announcements | Ergomed plc: Results of 2022 Annual General Meeting
Investegate announcements from Ergomed plc, Results of 2022 Annual General Meeting
Source: investegate.co.uk
Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression
/PRNewswire/ -- Companies in the Ovarian Cancer market are spending a lot of R&D on vaccine development, therapies and studies. For the past 30 years,...
Source: prnewswire.com